Since 2012, CO*RE has delivered in-person and online Opioid Analgesics REMS education to more than 600,000 clinicians via more than 600 CE/CME activities (through November 2022). The most recent full year of programming (2019) saw over 72,000 learners alone.
CO*RE uses a Common Outcomes Framework to align the FDA Blueprint with CO*RE learning objectives, content, and assessment questions. This makes for consistency across courses and allows for more robust data analysis on educational impact.
CO*RE learner data is compiled in a custom dashboard, which allows us to identify patterns and look for additional gaps to be addressed. For example, here are key learnings from our 2019 Outcomes Report:
- Learners at in-person live activities scored higher on posttests than learners in online activities
- Learners with individual DEA registration scored higher than those with institutional DEA or none
- Learners in our Adaptive Learning course demonstrated 36% improvement in confidence in opioid rotation and in using the ORT OUD
- Learners reported making more changes after the education than they had planned (see figure)